VF
CGTX icon

Virtu Financial’s Cognition Therapeutics CGTX Stock Holding History

Virtu Financial’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53K Buy
70,162
+30,174
+75% +$35.1K ﹤0.01% 1279
2025
Q4 		$54K Buy
+39,988
New +$64.9K ﹤0.01% 1294
2025
Q1 		– Sell
-80,180
Closed -$56K – 1429
2024
Q4 		$56K Buy
80,180
+22,949
+40% +$11.3K ﹤0.01% 1142
2024
Q3 		$27K Buy
+57,231
New +$59K ﹤0.01% 1096
2024
Q1 		– Sell
-11,347
Closed -$21K – 1480
2023
Q4 		$21K Buy
+11,347
New +$15K ﹤0.01% 1314

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Virtu Financial's CGTX Position: Q1 2026 in Review

Virtu Financial increased its Cognition Therapeutics (CGTX) stake by 75% in Q1 2026, buying an estimated $35.1K and bringing the position to 70,162 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #1279.

Virtu Financial first reported a position in CGTX in Q4 2023 and has held it in 5 quarters since. The position peaked at $56K in Q4 2024. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • Virtu Financial held 70,162 shares of Cognition Therapeutics worth $53K as of Q1 2026.
  • Virtu Financial bought 30,174 Cognition Therapeutics shares in Q1 2026, an estimated $35.1K.
  • Cognition Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1279 holding.
  • Virtu Financial first reported a position in Cognition Therapeutics in Q4 2023 and has held it in 5 quarters since.
  • Virtu Financial's Cognition Therapeutics position peaked at $56K in Q4 2024.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.